In silico analysis of whole transcriptomics data from the cohort of 264 patients with precursor T-cell neoplasm has allowed us to identify specific genetic signatures in patients with reduced FADD levels (FADD-negative phenotype). Here, FADD is linked to T-cell and NK-cell neoplasm.